Vivo Bio Tech enters long-term contract with Bio E
Biotech

Vivo Bio Tech enters long-term contract with Bio E

The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years

  • By IPP Bureau | August 30, 2021

Vivo Bio Tech Ltd, a leading Contract Research Services and Lab animal supply company has entered into a long term supply contract for various products & services with Biological E, one of the largest vaccine manufacturers of India, as a preferred vendor. The value of the contract is estimated to be in the range of Rs 20-30 crores per year, for the next three years.

Vivo Bio Tech is a full-service CRO offering drug development & discovery services to pharmaceutical & biotech companies worldwide following OECD - GLP, AAALAC & IND guidelines.

The company offers services in the areas of In vivo & In vitro toxicity studies, pharmacological investigations, pharmacokinetic & toxicokinetic studies, genotoxicity screening, analytical services etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.

Upcoming E-conference

Other Related stories

Startup

Digitization